More on the history of arrhythmia in long QT syndrome  by Csanády, Miklós
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aore on the History of
rrhythmia in Long QT Syndrome
read with great interest the report by Etheridge et al. (1)
ntitled “A New Oral Therapy for Long QT Syndrome.”
First, I should like to congratulate the investigators for
heir valuable contribution. They found that in patients with
ong QT syndrome due to HERG mutations there was an
mprovement in repolarization in parallel with a normaliz-
ng serum potassium level after oral potassium (and spirono-
actone) administration.
Their final sentence summarizes the present situation as
ollows: “Further studies are warranted to determine
hether they will reduce the incidence of life-threatening
vents in LQTS patients” (1).
We agree with this statement completely, but I would
dditionally draw the attention of the authors of the study
nd the Editorial Comment (2) to the family reported by
amstorp et al. (3) some 40 years ago. Although the
ffected members of the family were slightly hypokalemic,
he administration of potassium led not only to a diminish-
ent of the electrocardiographic abnormalities but also to
essation of the Adams-Stokes attacks.
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EPLY
e thank Dr. Csanády for his interest in our report (1) and
or bringing to our attention the report by Gamstorp et al.
2) of a family whose members presented with syncope
ssociated with hypokalemia. Although hypokalemia is a
nown trigger for life-threatening arrhythmia in long QT
yndrome (LQTS) patients, the consistent finding of hypo-
alemia in this family suggests a fundamental abnormality df potassium homeostasis. Hypokalemia is a common fea-
ure of Andersen-Tawil syndrome, triggering both skeletal
uscle paralysis and ventricular arrhythmias. We would like
o emphasize that no subject in our study was hypokalemic
t baseline, and therefore the therapy did not normalize
atients’ serum potassium but, rather, increased their serum
otassium to the upper limits of normal.
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mpaired Vascular Reactivity in
atients With Erectile Dysfunction
n the January 21, 2004 issue of the Journal, Kaiser et al. (1)
eported about endothelial function in patients with erectile
ysfunction (ED) and no vascular risk factors. They found
his group as having significantly less vasodilation to both
schemia (endothelium dependent) and nitroglycerin (endo-
helium independent) stimuli than normal subjects. These
ata led the investigators to conclude there was a peripheral
ascular defect occurring before the development of overt
ascular disease, thus reinforcing the concept of ED as an
arly marker for systemic vascular disease (1).
We believe that one major point needs clarification.
atients were classified as having ED according to the
nternational Index of Erectile Function (IIEF) (2). This
s a 15-item validated self-administered questionnaire that
xplores five domains of sexual function: erectile function,
rgasmic function, sexual desire, intercourse satisfaction,
nd overall satisfaction. Erectile function is specifically
ddressed by six questions, 1, 2, 3, 4, 5, and 15, which form
he so-called “erectile function domain” of the question-
aire. Each question is scored 0 (or 1) to 5 with a minimum
nd maximum score of 1 and 30, respectively. Erectile
ysfunction is defined as any value 26. Below this cut-off
